LONG-ACTING BRONCHODILATOR
| The Foradil brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your healthcare provider about safe options for transitioning to a different treatment. |
Overview
Foradil was a prescription drug first approved by the U.S. Food and Drug Administration (FDA) in 2001 for maintenance of asthma and prevention of bronchospasms in chronic obstructive pulmonary disease (COPD). Foradil was not indicated for acute attacks. Foradil was referred to by its drug name, formoterol.
Foradil was a bronchodilator, a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Foradil was believed to work by relaxing smooth muscles in the airways. Foradil was considered a long-acting bronchodilator.
How was it taken?
Foradil was inhaled orally twice a day.
Side effects
Common side effects listed in Foradil’s prescribing information upper respiratory tract infection, back pain, pharyngitis (sore throat), chest pain, sinusitis (inflammation of the sinuses), fever, leg cramps, muscle cramps, anxiety, pruritus (itching), increased sputum, and dry mouth.
Rare but serious side effects included worsening breathing problems, chest pain, fast or irregular heartbeat, high blood pressure, hypokalemia (low blood potassium levels), hyperglycemia (high blood sugar), tremors, dizziness, and allergic reactions. There was also a risk of paradoxical bronchospasm, where breathing worsens instead of improving after inhalation.
For more information about this treatment, visit:
Become a member to get even more